Publicaciones en colaboración con investigadores/as de Consiglio Nazionale delle Ricerche (24)

2022

  1. Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 42, Núm. 2, pp. 237-252

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Reactive astrocyte nomenclature, definitions, and future directions

    Nature Neuroscience, Vol. 24, Núm. 3, pp. 312-325

2020

  1. Nesfatin-1 decreases the motivational and rewarding value of food

    Neuropsychopharmacology, Vol. 45, Núm. 10, pp. 1645-1655

2017

  1. CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

    Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634

2016

  1. Astrocytes as secretory cells of the central nervous system: Idiosyncrasies of vesicular secretion

    EMBO Journal, Vol. 35, Núm. 3, pp. 239-257

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

2012

  1. Astroglial excitability and gliotransmission: An appraisal of Ca2+ as a signalling route

    ASN Neuro, Vol. 4, Núm. 2, pp. 103-119

  2. In vivo veritas, in vitro artificia

    Trends in Molecular Medicine

2010

  1. An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness

    Immunity, Vol. 33, Núm. 6, pp. 929-941

2009

  1. A model of ischemia-induced neuroblast activation in the adult subventricular zone

    PLoS ONE, Vol. 4, Núm. 4

2007

  1. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death

    Journal of Pharmacology and Experimental Therapeutics, Vol. 323, Núm. 1, pp. 70-77

  2. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

    British Journal of Pharmacology, Vol. 151, Núm. 7, pp. 1109-1116

2005

  1. The metabotropic P2Y 4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells

    Neurobiology of Disease, Vol. 18, Núm. 1, pp. 100-109

2004

  1. Role of the metabotropic P2Y4 receptor during hypoglycemia: Cross talk with the ionotropic NMDAR1 receptor

    Experimental Cell Research, Vol. 300, Núm. 1, pp. 149-158

  2. Synaptic P2X7 and Oxygen/Glucose Deprivation in Organotypic Hippocampal Cultures

    Journal of Cerebral Blood Flow and Metabolism, Vol. 24, Núm. 4, pp. 392-398

2003

  1. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: Prevention by P2 antagonists

    Neuroscience, Vol. 120, Núm. 1, pp. 85-98

2002

  1. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei

    Neuroscience, Vol. 115, Núm. 2, pp. 425-434

  2. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: Role of P2 and NGFRp75 receptors

    Journal of Neurochemistry, Vol. 83, Núm. 5, pp. 1129-1138

  3. P2 receptor modulation and cytotoxic function in cultured CNS neurons

    Neuropharmacology, Vol. 42, Núm. 4, pp. 489-501